-
Loading metrics
Safety and Immunogenicity of H1/IC31®, an Adjuvanted TB Subunit Vaccine, in HIV-Infected Adults with CD4+ Lymphocyte Counts Greater than 350 cells/mm3: A Phase II, Multi-Centre, Double-Blind, Randomized, Placebo-Controlled Trial
- Klaus Reither,
- Lynn Katsoulis,
- Trevor Beattie,
- Nicolene Gardiner,
- Nicole Lenz,
- Khadija Said,
- Elirehema Mfinanga,
- Christian Pohl,
- Katherine L. Fielding,
- Hannah Jeffery
x
- Published: December 9, 2014
- https://doi.org/10.1371/journal.pone.0114602